Research and Development

Showing 15 posts of 9612 posts found.

Inlyta image

NICE U-turn on Pfizer drug Inlyta

March 5, 2014 Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta

NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …
Cobra biologics image

Cobra agrees oncology deal with BioCancell

March 4, 2014 Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology

Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …
Clinical trials image

Clinical studies still not being published

March 4, 2014 Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr

Half of all trials registered on a US clinical study database are not being published in public journals. This is …
john_colby_-_cluepoints

CluePoints appoints three heads

March 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cluepoints, colby, polvent, stephenne

Clinical trial data firm CluePoints has announced three new appointments to its global team. John Colby (pictured) and Elizabeth Polvent join …
roche_logo_shadow

Roche lung cancer drug fails

March 3, 2014 Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin

An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
neil_flash

dna Medical Communications hires MD

March 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash

Neil Flash has joined healthcare agency dna Medical Communications as the managing director for its UK team. Flash joined dna …
Blood pressure image

Look beyond the screen

March 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials

It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …

Packer Forbes Communications adds managing director

February 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber

Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …
Novartis image

Novartis extends trial transparency

February 27, 2014 Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
novartis image

Novartis to axe Horsham site

February 27, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

Biotech industry failed by UK, says UCB

February 27, 2014 Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat

The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
dave_henderson_ipa_judge

Best of Health Awards judges appointed

February 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson

The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …
Esbriet image

InterMune scores in lung trial

February 26, 2014 Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
BMS image

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014 Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …
rupert_gowrley

Bupa hires MHP Health head

February 26, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health

Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …
The Gateway to Local Adoption Series

Latest content